| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2024 | 22 May 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Audited Financial Results for the fourth Quarter as well as financial year ended on 31st March 2024 along with Auditors Report thereon and Other routine matters with the permission of the chair. | ||
| Board Meeting | 6 Feb 2024 | 30 Jan 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve un-audited Financial Results for the quarter as well as nine months ended on 31st December 2023 along with Limited Review Report thereon and other routine matters with the permission of Chair. With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 04/2023-2024) held today i.e., Tuesday, 06th day of February, 2024, has inter alia, considered and approved the businesses as mentioned in the outcome. Further Un-Audited Financial Results of the Company shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting. The Un-Audited Financial Results of the Company shall also be uploaded on the Companys website i.e. www.biofilgroup.net and on the website of the Stock Exchanges i.e., at www.bseindia.com and www.nseindia.com and extracts of the aforesaid results shall also be published in Hindi (Vernacular) and widely circulated English Newspaper. This is for your information and record. Pursuant to regulation 33 of SEBI (LODR), Regulations, 2015, we are hereby enclosing un-audited financial results for the quarter as well as nine months ended 31st December, 2023 duly approved by the board of directors at its meeting held today i.e. 06th February, 2024 together with segment results and limited review report thereon. (Copy of Unaudited financial results along with limited review report is enclosed with this letter in searchable mode.) (As per BSE Announcement Dated on 06/02/2024) | ||
| Board Meeting | 9 Nov 2023 | 1 Nov 2023 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve un-audited Financial Results for the quarter as well as half year ended on 30th September 2023 along with limited review report thereon. and 2. Any other matter with the permission of chair. We are submitting the above said information in XBRL mode along with the submission in PDF mode. With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 03/2023-24) held on today i.e., Thursday, 09th day of November, 2023, has inter alia, transacted following matters along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September, 2023 along with Segment results, Statement of assets and liabilities, Cash Flow Statement and Limited Review Report (Copy of Unaudited financial Results for quarter as well as half year ended 30th September, 2023 being submitted separately). (As Per BSE Announcement dated on 09.11.2023) | ||
| Board Meeting | 14 Aug 2023 | 5 Aug 2023 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve un-audited Financial Results for the quarter ended on June 30 2023 along with the Limited Review Report thereon. 2. To consider the matters relating to the ensuing Annual General Meeting. Outcome of Board Meeting held on Monday 14th August, 2023 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement dated on 14.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
